042 - Biotech M&As accelerate. IMMU's ADC shakes up breast cancer!

06/27/19 • 19 min

Today, I cover the latest in biotech with a highlight on Immunomedics and their antibody-drug conjugates for breast cancer.

this is not investment advice www.breakingbiotech.com @matthewlepoire

Support Breaking Biotech by donating to the tip jar: https://tips.pinecast.com/jar/breaking-biotech

Today, I cover the latest in biotech with a highlight on Immunomedics and their antibody-drug conjugates for breast cancer.

this is not investment advice www.breakingbiotech.com @matthewlepoire

Support Breaking Biotech by donating to the tip jar: https://tips.pinecast.com/jar/breaking-biotech

Previous Episode

041 - Is REGENXBIO a buy after Zolgensma approval?

Today, I talk about REGENXBIO and their in-house gene therapy candidates. Their most important asset in early clinical trials is RGX-314, indicated for wet AMD (and hopefuily Diabetic Retinopathy). This gene therapy could replace blockbuster drugs that treat millions patients, but is it a buy today?

Follow me @matthewlepoire www.breakingbiotech.com

this is not investment advice

Support Breaking Biotech by donating to the tip jar: https://tips.pinecast.com/jar/breaking-biotech

Next Episode

043 - Sarepta keeps the gene therapy throne in DMD! ContraVir submits NASH IND!

Hey everybody, hope you're all doing well! In this video, I talk about Pfizer's DMD gene therapy update that indicates continued Sarepta hegemony in the space. I also talk about ContraVir and their NASH drug, CRV431.

I must have drank too much coffee before recording because I made more than a couple errors this time around. So, if you're an audio-only listener and hear something that doesn't sound right, double check the video version, which corrects the mistakes via captions or has it written properly even though I say it wrong (i.e. I say 3E16 when 3E13 is clearly written on the slide).

Thanks to everyone for listening and do your own due diligence if you are considering investing, this is not a substitute for investment advice.

www.breakingbiotech.com Follow me on twitter @matthewlepoire

Support Breaking Biotech by donating to the tip jar: https://tips.pinecast.com/jar/breaking-biotech